It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile


call (888) 352-RUSH for help arranging an appointment

Alfred Guirguis, DO

  • Gynecologic Oncology
  • Obstetrics and Gynecology
Board Certification:
  • Gynecologic Oncology
  • Obstetrics & Gynecology
Faculty Rank: Assistant Professor
Medical or Graduate Education: Arizona College of Osteopathic Medicine, Midwestern University
Residency: Rush University Medical Center - Obstetrics and Gynecology
Fellowship: University of Pittsburgh Medical Center - Obstetrics and Gynecology
Clinical Expertise:
  • Cervical cancer
  • Gynecologic cancer
  • Hysterectomy
  • Laparoscopy
  • Ovarian cancer
  • Polycystic ovary syndrome (PCOS)
  • Robotic surgery
  • Uterine cancer
  • Vaginal cancer
  • Vulvar cancer
Research Interests:
  • Molecular and gene profiling for gynecologic cancers
  • Clinical outcomes
Languages Spoken:
  • Arabic
Google Map
  • University Gynecologic Oncology Associates
  • 1725 W. Harrison St.
  • Suite 1010
  • Chicago, IL  60612
  • Phone: (312) 942-6300
  • Fax: (312) 942-6301
  • View Larger MapDriving Directions
Google Map
  • University Gynecologic Oncology Associates
  • 430 Warrenville Rd.
  • Suite 300
  • Lisle, IL  60532
  • Phone: (630) 724-8700
  • Fax: (630) 724-8702
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Interleukin 16 expression changes in association with ovarian malignant transformation.
    Yellapa A, Bitterman P, Sharma S, Guirguis AS, Bahr JM, Basu S, Abramowicz JS, Barua A
    Am. J. Obstet. Gynecol.
    2014 Mar
  2. Immunohistochemical characterization of squamous differentiation and morular metaplasia in uterine endometrioid adenocarcinoma.
    Blanco LZ Jr, Heagley DE, Lee JC, Gown AM, Gattuso P, Rotmensch J, Guirguis A, Dewdney S, Bitterman P.
    Int J Gynecol Pathol. 2013
    2013 May
    32(3):283-92. doi: 10.1097/PGP.0b013e31826129e1.
  3. Use of cervical mucus to screen for gynecological malignancies: a pilot study.
    Lamzabi I, Buckingham L, Gebrekiristos M, Jain R, Gattuso P, Reddy V, Guirguis A, Dewdney S, Rotmensch J, Bitterman P.
    Mod Pathol. 2013
    2013 Jun 14. doi: 10.1038/modpathol.2013.92. [Epub ahead of print]
  4. Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.
    Kolbe DL, DeLoia JA, Porter-Gill P, Strange M, Petrykowska HM, Guirguis A, Krivak TC, Brody LC, Elnitski L.
    PLoS One. 2012
    7(3):e32941. doi: 10.1371/journal.pone.0032941. Epub 2012 Mar 5.
  5. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
    Patsavas K, Woessner J, Gielda B, Rotmensch J, Yordan E, Bitterman P, Guirguis A.
    Gynecol Oncol. 2011
    2011 Jun 1
    121(3):581-5. doi: 10.1016/j.ygyno.2010.11.048. Epub 2011 Mar 25.
  6. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
    Guirguis A, Elishaev E, Oh SH, Tseng GC, Zorn K, DeLoia JA.
    Gynecol Oncol. 2008
    2008 Feb
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript